kabutan

SAPPORO CLINICAL LAB, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 33%, Exceeds Full-Year Plan

Wed Feb 12, 2025 3:30 pm JST Earnings

9776 SAPPORO CLINICAL LABORATORY INC. 【J-GAAP】

Earnings Report

SAPPORO CLINICAL LABORATORY INC. <9776> [TSE Std] announced its financial results after the market closed on February 12th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) expanded 553 million yen, an increase 32.6% compared to the same period last year. The progress rate toward the full-year plan of 493 million yen is 112.2%, already exceeding the target and also exceeding the five-year average of 75.5%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the January to March period (4Q) is expected to turn into a loss of 60 million yen (compared to a profit of 97 million yen in the same period last year).

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit increased 73.6% from the same period last year, reaching 210 million yen. The operating profit margin improved from 2.5% in the same period last year to 3.9%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2022 15,250 816 971 493 147.9 83.8 Feb 10, 2023 J-GAAP
Apr - Dec, 2023 14,852 414 417 311 93.7 81.1 Feb 9, 2024 J-GAAP
Apr - Dec, 2024 15,275 541 553 367 117.2 112.2 Feb 12, 2025 J-GAAP
YoY +2.8% +30.7% +32.6% +18.0% +25.1%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 9,820 243 218 154 46.3 23 May 13, 2024 J-GAAP
Oct - Mar, 2024 Guidance 9,803 163 150 98 31.4 23 Nov 1, 2024 J-GAAP
YoY -0.2% -32.9% -31.2% -36.4% -32.1%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 20,127 1,008 1,159 568 170.5 23 May 12, 2023 J-GAAP
Mar, 2024 19,682 534 514 380 114.1 23 May 13, 2024 J-GAAP
Mar, 2025 Guidance 19,799 500 493 320 102.6 23 May 13, 2024 J-GAAP
YoY +0.6% -6.4% -4.1% -15.8% -10.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 4,990 123 121 85 25.6 2.5 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 4,830 120 97 69 20.7 2.5 May 13, 2024 J-GAAP
Apr - Jun, 2024 4,999 98 102 56 17.9 2.0 Aug 5, 2024 J-GAAP
Jul - Sep, 2024 4,997 239 241 166 53.0 4.8 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 5,279 204 210 145 46.3 3.9 Feb 12, 2025 J-GAAP
YoY +5.8% +65.9% +73.6% +70.6% +80.9%

Related Articles